文献检索，用中文搜 PubMed

Suppr 超能文献

核心技术专利：CN118964589B侵权必究

核心技术专利：CN118964589B侵权必究

Department of Psychiatry, McGill University, Montreal, Canada.

Prog Neuropsychopharmacol. 1979;3(1-3):271-5. doi: 10.1016/0364-7722(79)90090-0.

Research is an important area within the purview of medical ethics. The Nuremberg Code and the Helsinki Declaration provide well established guidelines in this field. 2. Specific ethical issues still requiring clarification in psychopharmacological research are the informed consent, the benefit/risk ratio and the choice of placebo or standard. 3. Peer review committees, if well chosen for their objectivity, general competence and special expertise, are likely to be the best arbiters regarding such questions. 4. Legislation and other political interventions--unfortunately not always objective, competent or expert in the exercise of their powers--have recently developed into rampant paraethical problems that are plaguing medical treatment and research in many parts of the world and need to be dealt with urgently through internationally coordinated efforts. The WHO would appear to be the most appropriate agency for such action.

Prog Neuropsychopharmacol. 1979;3(1-3):271-5. doi: 10.1016/0364-7722(79)90090-0.

J Med Ethics. 1983 Jun;9(2):66-8. doi: 10.1136/jme.9.2.66.

Science. 2000 Apr 21;288(5465):416. doi: 10.1126/science.288.5465.416a.

Account Res. 1993;3(1):1-17. doi: 10.1080/08989629308573826.

NCEHR Commun. 1997;8(2):11-5.

Prog Neuropsychopharmacol. 1979;3(1-3):297-301. doi: 10.1016/0364-7722(79)90095-x.

N Y Times Web. 1994 Mar 14:A16.

Am J Psychiatry. 1984 Mar;141(3):400-5. doi: 10.1176/ajp.141.3.400.

Soc Sci Med. 1982;16(20):1791-800. doi: 10.1016/0277-9536(82)90273-8.

J Calif Alliance Ment Ill. 1994;5(1):61-2.

Department of Psychiatry, McGill University, Montreal, Canada.

Prog Neuropsychopharmacol. 1979;3(1-3):271-5. doi: 10.1016/0364-7722(79)90090-0.

Research is an important area within the purview of medical ethics. The Nuremberg Code and the Helsinki Declaration provide well established guidelines in this field. 2. Specific ethical issues still requiring clarification in psychopharmacological research are the informed consent, the benefit/risk ratio and the choice of placebo or standard. 3. Peer review committees, if well chosen for their objectivity, general competence and special expertise, are likely to be the best arbiters regarding such questions. 4. Legislation and other political interventions--unfortunately not always objective, competent or expert in the exercise of their powers--have recently developed into rampant paraethical problems that are plaguing medical treatment and research in many parts of the world and need to be dealt with urgently through internationally coordinated efforts. The WHO would appear to be the most appropriate agency for such action.